NATURE'S SUNSHINE PRODUCTS News

Nature's Sunshine Recalls Andrographis Supplement in Australia Over Anaphylaxis Risk

Therapeutic Goods Administration | 10/28/2026

CANBERRA, Australia - October 28, 2026

Nature's Sunshine Products has begun a consumer-level recall of its Andrographis herbal supplement in Australia, joining a growing list of companies pulling products that contain the herb after the country's medicines regulator concluded that the risk of severe allergic reactions could no longer be managed with warning labels.

The recall, recorded by the Therapeutic Goods Administration (TGA) as action RC-2026-RN-00869-1, began on October 28, 2026. It covers Nature's Sunshine Andrographis, listed on the Australian Register of Therapeutic Goods as AUST L 302367. The TGA classifies the action as a Class I recall at the consumer level, the most serious hazard category the agency uses. The responsible entity is Nature's Sunshine Products of Australia Pty Ltd, the Australian arm of the Lehi, Utah-based direct selling company. The recall record identifies batch 2212, with an expiry date of October 2028, while the TGA's consolidated Andrographis recall list, updated October 30, describes the action as covering all unexpired batches of the product.

Andrographis paniculata is an herb long sold in immune-support and cold-and-flu formulas. Since 2019, listed medicines in Australia containing the ingredient have been required to carry a label warning about the risk of allergic reactions, including anaphylaxis. According to the TGA, reports of anaphylaxis linked to Andrographis products continued at a sustained high level despite those warnings, including a fatal case reported in June 2024.

After publishing an updated safety review and supplementary report in April 2026 and taking public submissions, the TGA removed Andrographis from the list of ingredients permitted in low-risk listed medicines, effective September 17, 2026. The change barred new Andrographis products from being listed, but did not automatically remove products already on the market. Instead, the regulator asked sponsors to voluntarily cancel their listings or recall their products, and said it would begin taking regulatory action, including possible compulsory recalls or cancellations, from mid-October 2026 for companies that did not act.

Nature's Sunshine is the latest in a long line of sponsors to respond. The TGA's recall list now includes more than 30 Andrographis-containing products from more than 20 sponsors, including well-known supplement brands and pharmacy private labels, ranging from immune-support capsules to cold-and-flu tablets.

The TGA is advising consumers who have the Nature's Sunshine product not to use it. Customers can return it to the place of purchase or contact Nature's Sunshine customer service on 1800 687 577 to arrange a return and refund. Wholesalers have been told to inspect their stock immediately and quarantine all Andrographis product on hand. The agency notes that Andrographis reactions are unpredictable, can occur the first time a person takes the herb or after earlier use without problems, and often happen within 30 minutes. Anyone who may be experiencing anaphylaxis should call 000 immediately.

The recall is limited to the Australian market and to a single product. Nature's Sunshine Products, Inc., which trades on Nasdaq under the symbol NATR, sells herbal supplements, vitamins and personal care products through independent distributors and online channels in markets around the world. The company is scheduled to report its third quarter 2026 results on November 4.

Natures Sunshine Names Ruth Perkins Chief Financial Officer Effective September 1

Press Release | 8/6/2026

LEHI, Utah -- August 6, 2026

Natures Sunshine Products said its board appointed Ruth Perkins as executive vice president and chief financial officer effective September 1, 2026. Jon Lanoy will continue as principal accounting officer.

Perkins, 46, most recently served as senior vice president of global value chain finance at The Estee Lauder Companies since July 2023 and earlier held finance leadership roles at PepsiCo and Ford Motor Company. The company said she brings more than 20 years of finance experience across global consumer products companies.

The appointment was disclosed in the same Form 8-K package as second-quarter earnings.

Natures Sunshine Second Quarter Net Sales Rise 2 Percent to 117 Million Dollars

Press Release | 8/6/2026

LEHI, Utah -- August 6, 2026

Natures Sunshine Products reported second-quarter 2026 net sales of 117.0 million dollars, up 2% from 114.8 million dollars a year earlier and up 4% in constant currency. Gross profit margin rose 194 basis points to 73.7% from 71.7%.

GAAP net income attributable to common shareholders was 3.5 million dollars, or 0.19 dollars per diluted share, compared with 5.3 million dollars, or 0.28 dollars per share, a year earlier. Adjusted EBITDA was 11.3 million dollars.

The company separately announced the appointment of Ruth Perkins as executive vice president and chief financial officer effective September 1, 2026.

Natures Sunshine CFO Shane Jones to Resign; Jonathan Lanoy Named Interim Finance Chief

SEC Filing | 5/11/2026

Nature's Sunshine Products said Chief Financial Officer L. Shane Jones notified the company on May 8, 2026, that he will resign effective June 5, 2026, and that Senior Vice President and Chief Accounting Officer Jonathan D. Lanoy has been appointed interim principal financial officer.

The company said Jones's resignation was not the result of any disagreement on financial reporting or accounting policies, procedures, estimates or judgments. Lanoy, 51, has been chief accounting officer and principal accounting officer since January 2023 and previously served as vice president of finance and corporate controller. His employment agreement provides an annual base salary of 301,551 dollars and a target bonus of 50% of base salary.

The leadership change came four days after Nature's Sunshine reported a 9% rise in first-quarter net sales.

Natures Sunshine First Quarter Net Sales Rise 9 Percent to 122.9 Million Dollars

Press Release | 5/7/2026

LEHI, Utah -- May 7, 2026

Nature's Sunshine Products reported first-quarter 2026 net sales of 122.9 million dollars, up 9% from 113.2 million dollars a year earlier, or 7% in constant currency.

Gross margin rose 116 basis points to 73.2%. GAAP net income attributable to common shareholders was 5.1 million dollars, or 0.29 dollars per diluted share, up 16% from 0.25 dollars a year earlier, and adjusted EBITDA rose 33% to 14.6 million dollars. Management described the quarter as strong across markets and said it continued to invest in manufacturing and brand initiatives.

The results preceded a May 11 disclosure that CFO L. Shane Jones would resign effective June 5, with chief accounting officer Jonathan Lanoy named interim principal financial officer.

Nature's Sunshine Reports Record 2025 Sales of 480.1 Million Dollars

Press Release | 3/10/2026

LEHI, Utah -- March 10, 2026

Nature's Sunshine Products reported fourth-quarter 2025 net sales of 123.8 million dollars, up 4.7 percent from a year earlier, net income of 4.1 million dollars, or 0.23 dollars per diluted share, and adjusted EBITDA of 11.9 million dollars, up 16 percent. For the full year, net sales rose 5.7 percent to a record 480.1 million dollars, net income was 19.5 million dollars, or 1.06 dollars per share, and adjusted EBITDA increased 21.7 percent to 49.4 million dollars.

The company said new customers in its digital channels grew 98 percent in the fourth quarter, driving a 47 percent increase in its digital business and accelerating North America growth to 6 percent, with solid results in China, Japan, Korea and Europe. Nature's Sunshine ended the year with 93.9 million dollars in cash and no debt.

For 2026, the company expects net sales of 500 million to 515 million dollars and adjusted EBITDA of 50 million to 54 million dollars. "We finished a record year in sales and delivered our second-best quarter ever and our largest Q4 on record," said Chief Executive Ken Romanzi.

Nature's Sunshine Names Former B&G Foods Chief Kenneth Romanzi CEO to Succeed Terrence Moorehead

Press Release | 10/15/2025

LEHI, Utah -- October 15, 2025

Nature's Sunshine Products said its board has appointed Kenneth Romanzi chief executive officer, succeeding Terrence Moorehead. Romanzi will take the role and join the board on October 29, 2025, the date Moorehead resigns under a separation agreement. Moorehead told the board in May that he planned to step down, prompting a search for his successor.

Romanzi, 65, served as president and chief executive of B&G Foods from 2019 to 2020 after serving as its chief operating officer. Earlier he held leadership roles at Nabisco, The Ultimate Juice Company, including the Naked Juice brand, Hasbro and Ocean Spray, and most recently served as an operating partner at Ronin Equity Partners and a strategic advisor at Astara Capital Partners, both private equity firms. Under his employment agreement, he will receive an annual base salary of 850,000 dollars and restricted stock units valued at 1.5 million dollars that vest over three years, according to a regulatory filing.

"Ken is a transformational leader with a proven ability to grow, scale and drive innovation at high-caliber and complex CPG businesses," said Chairman Heidi Wissmiller, adding that his skills will help the company digitally empower distributors and practitioners and expand its omnichannel offerings. Romanzi said he was excited to join and lead the organization as it continues to transform consumers' lives globally through natural health.

Nature's Sunshine Second Quarter Sales Rise 4 Percent; Raises 2025 Outlook

Press Release | 7/31/2025

LEHI, Utah -- July 31, 2025

Nature's Sunshine Products reported second-quarter 2025 net sales of 114.8 million dollars, up 4 percent from 110.6 million dollars a year earlier, or up 2 percent in constant currency. Net income attributable to common shareholders rose to 5.3 million dollars, or 0.28 dollars per diluted share, from 1.3 million dollars, or 0.07 dollars, and adjusted EBITDA rose 8 percent to 11.3 million dollars.

Asia sales rose 5.4 percent to 52.7 million dollars and North America rose 4.2 percent to 35.0 million dollars, while Europe was up 0.6 percent at 21.7 million dollars and Latin America and other markets slipped 0.6 percent. Chief Executive Terrence Moorehead, who is staying on until a successor is found, pointed to strength in Japan and Central Europe and momentum in the company's digital business and autoship program.

The company raised its full-year 2025 outlook to net sales of 460 million to 475 million dollars, from 445 million to 470 million dollars, and adjusted EBITDA of 41 million to 45 million dollars, from 38 million to 44 million dollars. Nature's Sunshine repurchased 1,011,000 shares for 12.4 million dollars in the first half and ended June with 81.3 million dollars in cash and no debt.

Nature's Sunshine to Buy Out Fosun's 20 Percent Stakes in China Joint Ventures for 7 Million Dollars

SEC Filing | 7/7/2025

Nature's Sunshine Products disclosed in a regulatory filing that it has agreed to buy Fosun Industrial's minority interests in its two China joint ventures for a combined 7.0 million dollars in cash, giving the herbal supplement maker sole ownership of its business in the country.

Under share purchase agreements signed June 30, 2025, Nature's Sunshine will pay 3.9 million dollars for Fosun's interest in Nature's Sunshine Hong Kong Limited and 3.1 million dollars for its interest in Shanghai Nature's Sunshine Health Products Co. The joint ventures, formed in 2014 with Shanghai Fosun Pharmaceutical, have been owned 80 percent by Nature's Sunshine and 20 percent by Fosun Industrial and market the company's products in China.

The operating agreements required the buyout once Fosun Pharma and its affiliates owned less than 5 percent of Nature's Sunshine's common stock. That threshold was crossed on June 27, 2025, when a Fosun affiliate sold 2,854,607 shares in a secondary offering. The purchases are subject to customary closing conditions, including regulatory submissions to China's State Administration for Market Regulation and Ministry of Commerce.

Nature's Sunshine Prices Secondary Offering of Fosun Pharma's 2.85 Million Shares; May Buy Back Up to 15 Million

Press Release | 6/26/2025

LEHI, Utah, June 26, 2025 --

Nature's Sunshine Products said it priced an underwritten secondary public offering of up to 2,854,607 shares of its common stock being sold by Fosun Pharma USA Inc. at 12.00 dollars per share. The offering was expected to close on June 27, 2025. Fosun will receive all net proceeds, and Nature's Sunshine is not selling any shares.

As part of the offering, the company agreed with Fosun that it may buy up to 15.0 million dollars of the offered shares from the underwriters at the public offering price under its previously announced share repurchase program, funded from cash on hand and its credit facility, though it has not committed to a minimum purchase. D.A. Davidson and Co. is acting as sole book-running manager.

The offering was made under a shelf registration filed on June 9, 2025, that became effective on June 18. Fosun agreed to a 90-day lockup. A subsequent regulatory filing showed that after the offering closed, Fosun Pharma beneficially owned 64,167 shares, or about 0.35 percent of the company, largely ending a stake it had held since 2014.

Nature's Sunshine CEO Terrence Moorehead to Step Down; Board Launches Search for Successor

Press Release | 6/2/2025

LEHI, Utah, June 2, 2025 --

Nature's Sunshine Products said President and Chief Executive Terrence Moorehead notified the board on May 28, 2025, that he will step down as chief executive and resign from the board once a successor is appointed. Moorehead has led the herbal and nutritional supplement company for nearly seven years, since 2018.

The board has retained a national executive search firm to identify the company's next chief executive, and Moorehead will stay in his role while the search is conducted. Board Chair Heidi Wissmiller credited Moorehead with guiding the company through significant global uncertainty and setting it up for its next chapter of growth, while Moorehead pointed to progress in revitalizing the brand, expanding digital initiatives and driving customer growth.

Nature's Sunshine also reaffirmed its full-year 2025 outlook, which calls for net sales of 445 million to 470 million dollars and adjusted EBITDA of 38 million to 44 million dollars.

Nature's Sunshine First Quarter Sales Rise 2 Percent; Board Approves New 25 Million Dollar Buyback

Press Release | 5/6/2025

LEHI, Utah, May 6, 2025 --

Nature's Sunshine Products reported first-quarter 2025 net sales of 113.2 million dollars, up 2 percent from a year earlier and up 5 percent in constant currency. Asia sales rose 5.3 percent to 48.7 million dollars and Europe grew 8.2 percent to 24.1 million dollars, while North America fell 4.1 percent to 35.0 million dollars.

Net income doubled to 4.7 million dollars, or 0.25 dollars per diluted share, from 2.3 million dollars a year earlier. Adjusted EBITDA rose 20 percent to 11.0 million dollars and gross margin was 72.1 percent.

The board authorized a new share repurchase program of up to 25 million dollars, adding to 8.3 million dollars remaining under its prior authorization. The company ended the quarter with 86.5 million dollars in cash and no debt and reiterated its 2025 outlook for net sales of 445 million to 470 million dollars and adjusted EBITDA of 38 million to 44 million dollars. Terrence Moorehead is president and chief executive.

Nature's Sunshine Fourth Quarter Sales Rise 8.5 Percent to 118 Million; Posts Small Loss

Press Release | 3/11/2025

LEHI, Utah, March 11, 2025 --

Nature's Sunshine Products reported fourth-quarter 2024 net sales of 118.2 million dollars, up 8.5 percent from 108.9 million dollars a year earlier, or 10.0 percent in constant currency, led by 20.8 percent constant-currency growth in Asia. The company posted a net loss attributable to shareholders of 0.3 million dollars, or 0.02 dollars per diluted share, compared with net income of 9.0 million dollars a year earlier, as foreign-exchange losses and higher taxes weighed. Adjusted EBITDA rose 6 percent to 10.3 million dollars.

Chief Executive Terrence Moorehead called it one of the company's strongest quarters ever, citing Asia Pacific growth, execution in Europe and a 17 percent rise in North America digital sales. Full-year net sales rose 2.0 percent to 454.4 million dollars, while net income fell to 7.7 million dollars from 15.1 million dollars.

The company forecast 2025 net sales of 445 million to 470 million dollars and adjusted EBITDA of 38 million to 44 million dollars. It ended 2024 with 84.7 million dollars in cash and no debt.

Nature's Sunshine Third Quarter Sales Rise 3 Percent; Raises Full-Year Outlook

Press Release | 11/7/2024

LEHI, Utah, November 7, 2024 --

Nature's Sunshine Products reported third-quarter 2024 net sales of 114.6 million dollars, up 3 percent from 111.2 million dollars a year earlier, or 4 percent in constant currency. GAAP net income attributable to common shareholders rose to 4.3 million dollars, or 0.23 dollars per diluted share, from 2.8 million dollars, or 0.15 dollars, and adjusted EBITDA increased 5 percent to 10.7 million dollars.

Chief Executive Terrence Moorehead said the quarter delivered the year's highest sales volume, led by customer growth in Japan and Taiwan, progress in Korea and strong execution in Central Europe, partly offset by China macroeconomic headwinds. Asia sales rose 5.9 percent to 55.3 million dollars, or 8.6 percent excluding currency.

Given Asia softness, the company raised full-year 2024 net sales guidance to 443 million to 448 million dollars from 436 million to 445 million dollars and adjusted EBITDA guidance to 40 million to 42 million dollars from 39 million to 42 million dollars. It ended the quarter with 78.7 million dollars in cash and no debt.

Nature's Sunshine Second Quarter Sales Fall 5 Percent; Cuts Full-Year Outlook on Asia Weakness

Press Release | 8/8/2024

LEHI, Utah, August 8, 2024 --

Nature's Sunshine Products reported second-quarter 2024 net sales of 110.6 million dollars, down 5 percent from 116.5 million dollars a year earlier, or 3 percent in constant currency. Net income attributable to common shareholders fell to 1.3 million dollars, or 0.07 dollars per diluted share, from 2.4 million dollars, and adjusted EBITDA fell 8 percent to 10.4 million dollars.

Asia sales fell 8.9 percent and North America fell 3.2 percent, while Europe rose 1.7 percent. Chief Executive Terrence Moorehead cited macroeconomic headwinds in China, slower U.S. consumer spending and a temporary disruption in North America tied to a digital platform upgrade. He said the company cut more than 5 million dollars of annualized SG&A costs.

Citing softness in Asia, Nature's Sunshine lowered its full-year 2024 outlook to net sales of 436 million to 445 million dollars, from 455 million to 480 million dollars, and adjusted EBITDA of 39 million to 42 million dollars, from 42 million to 48 million dollars.

Nature's Sunshine First Quarter Sales Rise 2 Percent; Net Income More Than Doubles

Press Release | 5/7/2024

LEHI, Utah, May 7, 2024 --

Nature's Sunshine Products reported first-quarter 2024 net sales of 111.0 million dollars, up 2 percent from 108.6 million dollars a year earlier, or about 4 percent in constant currency, led by 5 percent growth in North America and a 33 percent surge in digital sales.

GAAP net income attributable to common shareholders rose to 2.3 million dollars, or 0.12 dollars per diluted share, from 0.9 million dollars, or 0.04 dollars. Adjusted EBITDA edged up to 9.2 million dollars from 9.1 million dollars. Gross margin expanded 33 basis points to 71.2 percent.

Chief Executive Terrence Moorehead said an omni-channel push and new Power Line products supported momentum, while Asia remained softer on China economic weakness. The company reiterated full-year 2024 net sales guidance of 455 million to 480 million dollars and adjusted EBITDA of 42 million to 48 million dollars. Cash stood at 77.8 million dollars.

Nature's Sunshine Fourth Quarter Sales Rise 6 Percent; Net Income More Than Triples

Press Release | 3/12/2024

LEHI, Utah, March 12, 2024 --

Nature's Sunshine Products reported fourth-quarter 2023 net sales of 108.9 million dollars, up 6.0 percent from 102.7 million dollars a year earlier, or 5.6 percent in constant currency. GAAP net income attributable to common shareholders rose to 9.0 million dollars, or 0.46 dollars per diluted share, from 2.0 million dollars, or 0.10 dollars. Adjusted EBITDA rose 21 percent to 9.7 million dollars.

Full-year sales were 445.3 million dollars, up 5.5 percent, or 7.3 percent in constant currency, with net income of 15.1 million dollars compared with a 0.4 million dollar net loss in 2022. Gross margin for the year expanded 110 basis points to 72.1 percent. Chief Executive Terrence Moorehead said North America delivered double-digit fourth-quarter growth and that gross-margin initiatives remained on track.

Cash and cash equivalents were 82.4 million dollars with no outstanding debt at year end. Nature's Sunshine guided 2024 net sales to 455 million to 480 million dollars and adjusted EBITDA to 42 million to 48 million dollars.

Natures Sunshine Third Quarter Net Sales Rise 6 Percent to 111.2 Million; Raises EBITDA Outlook

Press Release | 11/7/2023

LEHI, Utah, November 7, 2023 --

Nature's Sunshine Products reported third-quarter 2023 net sales of 111.2 million dollars, up 6 percent from 104.5 million dollars a year earlier, or 7.1 percent in constant currency. Asia sales rose 9.1 percent to 52.2 million dollars, up 12.4 percent in local currency, and North America rose 10.4 percent to 34.8 million dollars, while Europe fell 2.9 percent and Latin America and other fell 6.4 percent.

Gross margin improved 150 basis points to 73.1 percent. Net income attributable to common shareholders rose to 2.8 million dollars, or 0.15 dollars per diluted share, from 0.1 million dollars, and adjusted EBITDA increased 50 percent to 10.3 million dollars. Chief Executive Terrence Moorehead credited digital investments and improved field activation for North America's strongest growth in many years.

The company maintained its full-year 2023 net sales outlook of 443 million to 451 million dollars and raised its adjusted EBITDA forecast to 37 million to 40 million dollars from an original range of 34 million to 38 million dollars.

Natures Sunshine Second Quarter Net Sales Rise 12 Percent to 116.5 Million

Press Release | 8/9/2023

LEHI, Utah, Aug. 9, 2023 --

Nature's Sunshine Products reported second-quarter 2023 net sales of 116.5 million dollars, up 12 percent from 104.2 million dollars a year earlier, or 14 percent in constant currency. GAAP net income attributable to common shareholders was 2.4 million dollars, or 0.12 dollars per diluted share, versus 0.5 million dollars a year earlier. Adjusted EBITDA rose 26 percent to 11.3 million dollars.

Asia net sales rose 16 percent to 54.9 million dollars and Europe rose 24 percent to 21.2 million dollars, while North America rose 2 percent to 34.7 million dollars. Cash was 69.0 million dollars and debt was about 0.5 million dollars. The company guided full-year 2023 net sales of 440 million to 455 million dollars and adjusted EBITDA of 34 million to 38 million dollars.

Chief executive Terrence Moorehead said Asia/Pacific strength, Central and Eastern Europe stabilization and a return to North America growth supported the second-best sales quarter in company history.

Natures Sunshine First Quarter Net Sales Fall 2 Percent; Books Japan Fraud Charge

Press Release | 5/9/2023

LEHI, Utah, May 9, 2023 --

Nature's Sunshine Products reported first-quarter 2023 net sales of 108.6 million dollars, down 1.7 percent from 110.5 million dollars a year earlier, or up 2.4 percent in constant currency. GAAP net income was 1.3 million dollars, or 0.04 dollars per diluted share attributable to common shareholders, versus a loss a year earlier. Adjusted EBITDA was 9.1 million dollars compared with 8.2 million dollars.

SG&A rose to 43.6 million dollars and included a one-time 5.8 million dollar charge related to a financial loss from a criminal scheme directed at a wholly owned subsidiary in Japan, plus related investigation and professional fees. Cash was 65.7 million dollars and debt was about 1.0 million dollars. The company repurchased 90,000 shares for 0.8 million dollars in the quarter.

Chief executive Terrence Moorehead said Japan and Taiwan delivered strong double-digit growth and that digital initiatives were taking hold in North America despite a challenging external environment.

Natures Sunshine Fourth Quarter Net Sales Fall 13 Percent to 102.7 Million

Press Release | 3/15/2023

LEHI, Utah, March 15, 2023 --

Nature's Sunshine Products reported fourth-quarter 2022 net sales of 102.7 million dollars, down 12.9 percent from 117.9 million dollars a year earlier, or 6.4 percent in constant currency. GAAP net income was 2.1 million dollars, or 0.10 dollars per diluted share, and adjusted EBITDA was 8.0 million dollars compared with 11.6 million dollars.

Full-year net sales were 421.9 million dollars, down 5.0 percent reported but up 0.2 percent in constant currency. Full-year GAAP net income was 0.6 million dollars, with adjusted EBITDA of 32.0 million dollars versus 49.4 million dollars in 2021. Asia sales rose 5.3 percent for the year. Cash was 60.0 million dollars at year-end after 13.6 million dollars of share repurchases.

Chief executive Terrence Moorehead said fundamentals held despite external headwinds and that 2023 priorities include digital, field activation, manufacturing efficiency and brand-building investments.

Natures Sunshine Names Shane Jones Chief Financial Officer

Press Release | 12/6/2022

Nature's Sunshine Products appointed Shane Jones as chief financial officer effective December 30, 2022. Jones previously served as CFO of FullSpeed Automotive, West Marine, 1-800 Contacts and Backcountry.com, and held finance roles at Amazon, L Brands and YUM! Brands.

Jonathon Lanoy, who has served as interim CFO since September 6, will remain senior vice president of finance and corporate controller. President and chief executive Terrence Moorehead said Jones' track record of building high-performing teams will help the company continue to drive growth.

Natures Sunshine Third Quarter Net Sales Fall 9 Percent to 104.5 Million

Press Release | 11/3/2022

Nature's Sunshine Products reported third-quarter 2022 net sales of 104.5 million dollars, down 8.9 percent from 114.7 million dollars a year earlier and down 2.3 percent in constant currency. Net income was 0.2 million dollars, or 0.00 dollars per diluted share, compared with 5.5 million dollars, or 0.24 dollars. Adjusted EBITDA fell to 6.8 million dollars from 12.9 million dollars, and gross margin declined to 71.6 percent from 74.4 percent.

Asia sales were 47.9 million dollars, while North America sales fell 16.5 percent to 31.5 million dollars. Chief executive Terrence Moorehead said the company has committed to 10 million to 12 million dollars of cost savings over the next 18 months to offset inflation and currency pressure.

Natures Sunshine Second Quarter Net Sales Fall to 104.2 Million

Press Release | 8/9/2022

Nature's Sunshine Products said second-quarter 2022 net sales were 104.2 million dollars, down 4.4 percent from 109.0 million dollars a year earlier, or up 0.5 percent excluding currency. GAAP net income was 1.0 million dollars, or 3 cents per diluted common share, versus 6.8 million dollars, or 32 cents. Adjusted EBITDA was 9.0 million dollars, down from 13.4 million dollars.

Chief executive Terrence Moorehead said Asia growth and Europe losses left constant-currency sales roughly flat despite Ukraine war, inflation, supply-chain pressure, and lingering COVID effects. Asia sales rose 8.8 percent while Europe fell 20.3 percent and North America fell 8.8 percent. Cash was 56.3 million dollars at June 30 after about 12.0 million dollars of share repurchases in the first half.

Natures Sunshine Posts Record First Quarter Sales of 110.5 Million

Press Release | 5/5/2022

Nature's Sunshine Products said first-quarter 2022 net sales rose 8 percent to a company-record 110.5 million dollars. The company posted a GAAP net loss of 2.7 million dollars, or 15 cents per diluted share, versus net income of 4.2 million dollars a year earlier. Adjusted EBITDA fell to 8.2 million dollars from 11.6 million dollars.

Chief executive Terrence Moorehead said transformation initiatives and Asia growth supported sales while supply-chain and inflation pressures weighed on margin, including 4.2 million dollars of incremental inventory valuation charges, 3.1 million of which related to the Russia-Ukraine conflict. Cash and cash equivalents were 66.5 million dollars at March 31 after an 8.0 million dollar share repurchase in the quarter.

Natures Sunshine Posts Record Fourth Quarter Sales and Adds 30 Million Buyback

Press Release | 3/8/2022

Natures Sunshine Products said fourth-quarter 2021 net sales rose 15.9 percent to a record 117.9 million dollars, the sixth straight record quarter. GAAP net income rose to 13.8 million dollars, or 67 cents per diluted share, and adjusted EBITDA rose 54.7 percent to 11.6 million dollars. Full-year net sales rose 15.3 percent to a company-record 444.1 million dollars, with net income of 30.2 million dollars, or 1.42 dollars per diluted share.

Chief executive Terrence Moorehead credited the company's five global growth strategies. The board authorized up to 30 million dollars of additional share repurchases beyond a prior 15 million dollar program. Cash and cash equivalents were 86.2 million dollars at year-end. Management also flagged sales risk in Russia and Ukraine after the invasion while monitoring conditions.

Natures Sunshine Third Quarter Sales Rise 14 Percent to a Record 114.7 Million

Press Release | 11/4/2021

Natures Sunshine Products reported third quarter net sales of 114.7 million dollars, up 14 percent from 100.3 million dollars and the fifth straight record sales quarter. Excluding currency, sales rose 12.9 percent. Net income was 5.5 million dollars, or 0.24 dollars per diluted share, compared with 7.2 million dollars, or 0.34 dollars, a year earlier. Adjusted EBITDA rose 38 percent to 12.9 million dollars. Operating income rose 83 percent to 10.0 million dollars.

Asia sales were 48.4 million dollars, up 27 percent. Europe rose 21 percent. North America was about flat. Chief executive Terrence Moorehead said every market the company operates in was growing and credited rebranding, sales fundamentals, and the website. Gross margin improved to 74.4 percent. Volume incentives fell to 31.2 percent of sales from 34.2 percent.

Cash was 75.5 million dollars and debt was 2.7 million dollars. In the first nine months the company repurchased 350,000 shares for 6.0 million dollars and generated 20.3 million dollars of cash from operations. Net income attributable to common shareholders was 4.9 million dollars for the quarter.

Natures Sunshine Second Quarter Sales Rise 25 Percent to a Record 109 Million

Press Release | 8/5/2021

Natures Sunshine Products reported second-quarter net sales of 109.0 million dollars, up 25 percent from 87.3 million dollars and a fourth straight record quarter. GAAP net income rose 11 percent to 6.8 million dollars, or 0.32 dollars a diluted share, from 6.1 million dollars, or 0.29 dollars. Adjusted EBITDA rose 38 percent to a record 13.4 million dollars from 9.7 million dollars.

Chief executive Terrence Moorehead said Asia, Europe, and Latin America posted double-digit growth from product launches and execution of the five growth strategies. Asia sales were 43.5 million dollars, up 32.9 percent. Europe was 21.5 million dollars, up 38.7 percent. North America was 37.4 million dollars, up 8.4 percent. Latin America and other markets were 6.6 million dollars, up 44.0 percent. Excluding currency, consolidated sales rose 20.7 percent.

Moorehead said the direct-to-consumer business beat expectations and that a personalization program was planned later in the year. He also flagged supply-chain pressure and continued COVID-19 challenges, while saying the company remained financially sound.

Natures Sunshine Appoints Tariq Hassan to Its Board

Press Release | 7/7/2021

Natures Sunshine Products appointed Tariq H. Hassan to its board effective July 1, 2021. He will serve on the audit committee. The board now has nine directors, eight of them independent.

Hassan has more than 25 years in global brand strategy, communications, innovation, and insights. He was chief marketing officer at Petco, where the company said he helped reverse a two-year decline, deliver 11 straight quarters of growth, and lift e-commerce by more than 20 percent. Earlier he was a senior vice president at Bank of America Merrill Lynch, leading enterprise brand work and global wealth management marketing, and he held leadership roles at Hewlett Packard and Omnicom.

President and chief executive Terrence Moorehead said Hassan brings consumer marketing and digital experience to the company transformation. Hassan said he would work with the board and management on the five-point growth strategy. He holds a master of science from Northwestern University and an undergraduate degree from the University of Ontario.

Natures Sunshine First Quarter Sales Hit a Record 102.4 Million

SEC filing | 5/6/2021

Natures Sunshine Products reported record first-quarter net sales of 102.4 million dollars, up 7 percent from 95.9 million dollars a year earlier. It was the third straight quarter above 100 million dollars. GAAP net income attributable to common shareholders was 4.0 million dollars, or 0.20 dollars a share. Adjusted EBITDA rose 20 percent to 11.6 million dollars.

Chief executive Terrence Moorehead said Asia and Latin America led growth and that Europe was solid while North America faced a tough comparison with pandemic stockpiling a year earlier. Asia sales rose 15.5 percent. Latin America and Other rose 20.1 percent. Europe rose 7.6 percent. North America fell 2.6 percent.

Operating income was 7.6 million dollars. Cash and cash equivalents were 91.3 million dollars and debt was 3.3 million dollars at quarter end. The company had earlier declared a 1 dollar special dividend payable April 9, 2021.

Natures Sunshine Fourth Quarter Sales Hit a Record 101.7 Million

SEC filing | 3/10/2021

Natures Sunshine Products reported fourth-quarter net sales of 101.7 million dollars, up 11 percent from 91.7 million dollars and a company record. Net income attributable to common shareholders was 5.9 million dollars, or 0.29 dollars a diluted share, compared with 1.0 million dollars, or 0.05 dollars, a year earlier.

Full-year net sales rose 6.3 percent to a record 385.2 million dollars. Full-year net income attributable to common shareholders was 21.3 million dollars, or 1.07 dollars a share, compared with 6.8 million dollars, or 0.34 dollars, in 2019. Adjusted EBITDA for the year rose 16 percent to 36.2 million dollars. Cash was 92.1 million dollars, and debt outstanding was 3.7 million dollars.

The board declared a special cash dividend of 1.00 dollar a share, payable April 9, 2021, to shareholders of record on March 29. It also authorized repurchases of up to 15 million dollars of common stock. Chief executive Terrence Moorehead said all four operating units grew in the quarter and that 2020 was the highest sales year in the 48-year history of the company.

Europe led the quarterly sales gain, up 37.1 percent to 23.6 million dollars. North America rose 5.6 percent to 34.7 million dollars. Asia rose 2.3 percent, and Latin America and other markets rose 17.8 percent. Moorehead said a new brand and business model launched in the third quarter lifted customer acquisition and a subscribe-and-thrive membership.

Natures Sunshine Third Quarter Sales Hit a Record 100.3 Million

Npros.com | 11/10/2020

Natures Sunshine Products reported net sales of 100.3 million dollars for the third quarter ended September 30, 2020, up 13 percent from 88.5 million dollars a year earlier. The company said it was the highest consolidated net sales quarter in its history and that net income rose more than fourfold.

Chief executive Terrence Moorehead said consumer demand and new products sped momentum in the United States and China, while COVID-19 restrictions eased in Korea and Latin America and let the company use revamped field programs more fully. He said the transformation work is an early step and that the company expects the momentum to continue.

Segment net sales, in thousands of dollars, were 38,099 in Asia, up 13.0 percent from 33,717; 18,006 in Europe, up 23.0 percent from 14,640; 37,557 in North America, up 9.9 percent from 34,161; and 6,588 in Latin America and other markets, up 9.7 percent from 6,006.

Natures Sunshine Launches Rebrand Website and Faster Consultant Pay

Npros.com | 9/3/2020

Natures Sunshine Products said it is rolling out a revamped business model immediately, with new branding, a new website, and programs meant to change how consultants, health practitioners, and retailers work with the company.

Chief executive Terrence Moorehead said it has been nearly 50 years since the founding and that the company made a strategic decision to relaunch this fall. He said the new experience is built to respond to changing customer trends and to open growth opportunities for the field. A digital campaign called Force of Nature is planned to launch later in the year to raise brand awareness.

The company said the relaunch returns attention to its position as an herbal specialist. It said it was the first company to encapsulate herbs in 1972. The updated package includes refreshed branding, new sales tools, and a simpler compensation model with faster payments and larger earning opportunities.

Consultants will be able to create a dedicated web address on a revamped consumer site, run a digital business, and track customers and orders. A payment system called PayQuicker is intended to credit rewards from customer and downline purchases in real time, with the possibility of payment within 30 minutes of a purchase.

Natures Sunshine Products Reports First Quarter Financial Results

Press Release | 5/8/2012

Reinstatement of Quarterly Cash Dividend:

The Company's Board of Directors authorized a regular quarterly cash dividend of $0.05 per share, or $0.20 per share on an annual basis, payable on May 29, 2012 to shareholders of record as of the close of business on May 18, 2012. The Company suspended its dividend to shareholders on August 10, 2009, having previously paid a dividend every quarter since 1988. Michael Dean, Chief Executive Officer, stated: "We are pleased with the stability of our revenue, the improvement in our cash flow and the restoration of our strong balance sheet. These factors, combined with our growth prospects, have positioned us to reinstate the dividend to our shareholders on the occasion of Nature's Sunshine's 40th anniversary."

For the First Quarter of 2012:

-- Net sales were $92.9 million, compared with $92.8 million in the same quarter a year ago. -- As of March 31, 2012, active Managers worldwide were 29,800, a decrease of 1.7 percent from March 31, 2011, while active Distributors and customers worldwide were 675,400, a decrease of 3.0 percent from the end of the quarter a year ago. -- Operating income was $9.2 million, compared with $7.6 million in the same quarter a year ago, an increase of 20.4 percent. -- Adjusted EBITDA, defined here as net income before taxes, depreciation and amortization, and other income, adjusted to exclude share-based compensation expense, was $10.9 million, compared with $8.8 million in the same quarter a year ago, an increase of 24.3 percent. -- Net income was $7.2 million, compared with $6.6 million in the same quarter a year ago, an increase of 9.2 percent. -- Basic and diluted net income per share was $0.46 compared to $0.43 for the same quarter a year ago. -- As of March 31, 2012, shareholders' equity was $95.8 million, compared to $87.4 million on December 31, 2011, an increase of 9.6 percent.

Synergy Worldwide Results for the First Quarter:

-- Net sales were $23.3 million, compared with $20.7 million in the same quarter a year ago, an increase of 13.0 percent. In local currencies, net sales increased 15.5 percent. Active Managers within Synergy Worldwide totaled approximately 3,000 and 2,600 at March 31, 2012 and 2011, respectively. Active Distributors and customers within Synergy Worldwide totaled approximately 97,200 and 81,600 at March 31, 2012 and 2011, respectively. Synergy Worldwide is more network-marketing oriented, and the increase in net sales was primarily due to strong recruiting and retention of Managers and Distributors in our Korean and European markets. -- Operating income was $1.7 million, compared with $1.8 million for the same quarter in the prior year, a decrease of 8.8 percent. This decrease was primarily due to unusually high product returns during the quarter related to a specific promotion which contributed significantly to reduced net sales revenue in Japan. The products returns were not related to product quality.

Natures Sunshine Products Announces Annual Meeting Date

Press Release | 5/4/2012

The Company further announced that the deadline for the receipt of shareholder proposals for inclusion in the Company's proxy statement, and for nominations for directors, for the 2012 Annual Meeting is June 4, 2012. In order to be brought before the 2012 Annual Meeting, any such proposals must be received by the Corporate Secretary at the Company's principal executive offices no later than that date. Such proposals must comply in all respects with the requirements contained in the Company's bylaws and in Rule 14a-8 under the Securities and Exchange Act of 1934, as amended, to be considered a proper proposal or nomination.

Natures Sunshine in List of Top 5 Stocks Purchased by Insiders

Npros | 9/26/2011

Natures Sunshine Gets Ex Herbalife Board Member

Press Release | 6/20/2011

"We are excited to welcome Greg Probert to our Board of Directors and to his role as Executive Vice Chairman," said Kristine F. Hughes, Nature's Sunshine Chairman and a founder of the Company. "Greg brings tremendous experience in the direct selling industry. He has broad marketing and operational expertise that we know will serve our Board and benefit the Company and its shareholders." Michael Dean, Nature's Sunshine's President and CEO, added: "As a consultant, Greg's input has already proven valuable to the Company and we look forward to his expanded role as both executive and director."

Mr. Probert has served as a consultant in the direct selling industry since May 2008, including consulting with Nature's Sunshine since October 2010. At Nature's Sunshine, Mr. Probert has focused on the U.S. Sales division and participated in the Brilliant Body Brilliant Business initiative. Prior to his consulting work, Mr. Probert was the Chairman of the Board of Directors and Chief Executive Officer for Penta Water Company from December 2008 to March 2010. He also served as the President and Chief Operating Officer of Herbalife International from August 2003 to April 2008. Previously, Mr. Probert acted as the Chief Executive Officer of DMX Music and held significant management positions at iMovieStudio, PlanetLingo and served in various positions at the Walt Disney Company, including Executive Vice President of Worldwide Home Entertainment. Mr. Probert received his B.A. from the University of Southern California in 1979.

Natures Sunshine Under Heavy Scrutiny

Forbes | 7/16/2007

The company acknowledged Thursday that it had received a U.S. Securities and Exchange Commission subpoena for internal documents relating to operations in 32 other countries. The U.S. Department of Justice has requested the same documents, the company said.

Nature's Sunshine has failed to file quarterly or annual financial reports since 2005 and blames the resignation of auditor KPMG for the omission. KPMG has said it resigned because company executives failed to take its advice.